Harvard Public Health Dean Paid $150,000 as Expert Witness Against Tylenol Before Publishing Autism Research Used by Trump Administration
By
mathattack
8mo ago· 5 min readenNews
92/100
Golden Brown
Bagelometer↗
Baker's choice. Dense with flavour, light on filler.
Score92TypenewsSentimentnegative
Summary
Harvard School of Public Health Dean Andrea A. Baccarelli received at least $150,000 to testify as an expert witness against Tylenol's manufacturer Johnson & Johnson in 2023, linking the drug to autism. Two years later, he published research used by the Trump administration to support the same connection. However, a federal judge dismissed the case due to lack of scientific evidence, and experts say the causal link between Tylenol and autism remains tenuous at best. The article raises concerns about conflicts of interest and the integrity of academic research when financial incentives precede scientific findings.
Key quotes
· 3 pulledBaccarelli served as an expert witness on behalf of parents and guardians of children suing Johnson & Johnson, the manufacturer of Tylenol at the time.
U.S. District Court Judge Denise L. Cote dismissed the case last year due to a lack of scientific evidence, throwing out Bacca
a connection experts say is tenuous at best
Harvard School of Public Health Dean Andrea A. Baccarelli received at least $150,000 to testify against Tylenol’s manufacturer in 2023 — two years before he published research used by the Trump administration to link the drug to autism, even though expert
